Waters Corporation Operating CF per Share

Operating CF per Share of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF per Share growth rates and interactive chart. Total operating cash flow in a period divided by the weighted average number of shares outstanding. A company with $100 million in operating cash flow and 10 million weighted average shares will have operating cash flow per share of $10.


Highlights and Quick Summary

  • Operating CF per Share for the quarter ending December 30, 2020 was 4.31 (a 54.76% increase compared to previous quarter)
  • Year-over-year quarterly Operating CF per Share increased by 76.79%
  • Annual Operating CF per Share for 2020 was 12.73 (a 33.88% increase from previous year)
  • Annual Operating CF per Share for 2019 was 9.51 (a 21.13% increase from previous year)
  • Annual Operating CF per Share for 2018 was 7.85 (a -10.21% decrease from previous year)
  • Twelve month Operating CF per Share ending December 30, 2020 was 12.73 (a 10.41% increase compared to previous quarter)
  • Twelve month trailing Operating CF per Share increased by 28.0% year-over-year
Trailing Operating CF per Share for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
12.73 11.53 11.15 9.95
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF per Share of Waters Corporation

Most recent Operating CF per Shareof WAT including historical data for past 10 years.

Interactive Chart of Operating CF per Share of Waters Corporation

Waters Corporation Operating CF per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 4.31 2.78 3.21 2.44 12.73
2019 2.84 2.24 1.84 2.45 9.51
2018 2.36 1.91 1.29 2.23 7.85
2017 2.41 1.93 2.21 2.18 8.74
2016 2.15 1.84 1.97 1.99 7.96
2015 2.02 1.7 1.37 1.86 6.96
2014 1.92 1.53 1.26 1.36 6.07
2013 1.68 1.23 1.28 1.49 5.68
2012 1.5 1.16 1.19 1.25 5.11
2011 1.65 1.4 1.06 1.34 5.48
2010 1.45 1.19 1.21 4.96

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.